Correlation between efficacy of the biological therapy (tocilizumab) and levels of oxidative stress markers in Japanese patients with rheumatoid arthritis (inadequate responders to existing therapies)
Not Applicable
Recruiting
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000017230
- Lead Sponsor
- Kyushu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)The patients have an obvious infection in by just before treatment administration, and research investigator or research sharing doctor has determined that they are inappropriate for this study. 2)Based on the Japan College of Rheumatology "tocilizumab use guidelines for rheumatoid arthritis (2012 Revised Edition)", the patients correspond to the administration contraindication 3)The Patients who were considered as inappropriate by the other research doctors based on the medical backgrounds. 4)Under 20 years old
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evels of change in oxidative stress markers at 0, 6, and 12 months
- Secondary Outcome Measures
Name Time Method